These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36728881)

  • 41. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.
    Koh YX; Tan HJ; Liew YX; Syn N; Teo JY; Lee SY; Goh BKP; Goh GBB; Chan CY
    J Am Coll Surg; 2019 Nov; 229(5):467-478.e1. PubMed ID: 31398386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study.
    Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
    Eur J Intern Med; 2023 Jan; 107():66-72. PubMed ID: 36347739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease].
    Fang M; Yao M; Yang JL; Wang L; Sun JY; Wu MN; Yao DF; Tai BJ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):994-1000. PubMed ID: 31941262
    [No Abstract]   [Full Text] [Related]  

  • 46. [The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation].
    Li MR; Yi SH; Cai CJ; Yi HM; An YL; Wei M; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):271-4. PubMed ID: 21586225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
    Yang M; Wei L
    Liver Int; 2022 Aug; 42(9):1981-1990. PubMed ID: 35373500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.
    Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):64-71. PubMed ID: 15017634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    Viganò M; Bhoori S; Lampertico P; Donato MF; Iavarone M; Grossi G; Facciorusso A; Caccamo L; Rossi G; Colombo M; Mazzaferro V
    Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
    Li Q; Li H; Qin Y; Wang PP; Hao X
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short- and long-term outcomes of laparoscopic liver resection for non-alcoholic fatty liver disease-associated hepatocellular carcinoma: a retrospective cohort study.
    Watanabe Y; Aikawa M; Oshima Y; Kato T; Takase K; Watanabe Y; Okada K; Okamoto K; Koyama I
    HPB (Oxford); 2023 Dec; 25(12):1573-1586. PubMed ID: 37758580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.
    Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ
    J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
    Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease.
    Nguyen N; Rode A; Trillaud H; Aubé C; Manichon AF; Hocquelet A; Paisant A; Dao T; Nahon P; Ganne-Carrié N; Blaise L; Cauchy F; Sutter O; Séror O; Nault JC
    Liver Int; 2022 Apr; 42(4):905-917. PubMed ID: 34894060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.
    Vatansever S; Farajov R; Yılmaz HC; Zeytunlu M; Paköz ZB; Kılıç M
    Turk J Gastroenterol; 2019 Jan; 30(1):75-80. PubMed ID: 30644364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical management of hepatocellular carcinoma: resection or transplantation?
    Philosophe B; Greig PD; Hemming AW; Cattral MS; Wanless I; Rasul I; Baxter N; Taylor BR; Langer B
    J Gastrointest Surg; 1998; 2(1):21-7. PubMed ID: 9841964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.
    Zhou YM; Zhang XF; Li B; Sui CJ; Yang JM
    Ann Surg Oncol; 2014 Jul; 21(7):2406-12. PubMed ID: 24577811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
    Yu SJ; Kim YJ
    World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.